Potentiation of cystic fibrosis transmembrane conductance regulator (CFTR) Cl⁻ currents by the chemical solvent tetrahydrofuran

References

• Loudon GM. Organic chemistry4th ed. Oxford University Press, New York 2002; 318
   Google Scholar
• Koulov AV, Lambert TN, Shukla R, Jain M, Boon JM, Smith BD, Li H, Sheppard DN, Joos J-B, Clare JP, Davis AP. Chloride transport across vesicle and cell membranes by steriod-based receptors. Angew Chem Int Ed Engl 2003; 42: 4931–4933
   PubMed Web of Science ®Google Scholar
• Li H, Findlay IA, Sheppard DN. The relationship between cell proliferation, Cl− secretion, and renal cyst growth: A study using CFTR inhibitors. Kidney Int 2004; 66: 1926–1938
   PubMed Web of Science ®Google Scholar
• Welsh MJ, Ramsey BW, Accurso F, Cutting GR. Cystic fibrosis. The metabolic and molecular basis of inherited disease, CR Scriver, AL Beaudet, WS Sly, D Valle. McGraw-Hill Inc, New York 2001; 5121–5188
   Google Scholar
• Gadsby DC, Vergani P, Csanády L. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 2006; 440: 477–483
   PubMed Web of Science ®Google Scholar
• Cai Z, Chen J-H, Hughes LK, Li H, Sheppard DN. The physiology and pharmacology of the CFTR Cl( channel. Chloride movements across cellular membranes, M Pusch. Elsevier Ltd, San Diego 2007; 109–143
   Google Scholar
• Fischer H, Schwarzer C, Illek B. Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci USA. 2004; 101: 3691–3696
   PubMed Web of Science ®Google Scholar
• Zegarra-Moran O, Romio L, Folli C, Caci E, Becq F, Vierfond J-M, Mettey Y, Cabrini G, Fanen P, Galietta LJV. Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07. Br J Pharmacol 2002; 137: 504–512
   Google Scholar
• Rich DP, Berger HA, Cheng SH, Travis SM, Saxena M, Smith AE, Welsh MJ. Regulation of the cystic fibrosis transmembrane conductance regulator Cl− channel by negative charge in the R domain. J Biol Chem 1993; 268: 20259–20267
   PubMed Web of Science ®Google Scholar
• Sheppard DN, Robinson KA. Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl− channels expressed in a murine cell line. J Physiol 1997; 503: 333–346
   PubMedGoogle Scholar
• Cai Z, Taddei A, Sheppard DN. Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl− channel. J Biol Chem 2006; 281: 1970–1977
   PubMed Web of Science ®Google Scholar
• Lansdell KA, Cai Z, Kidd JF, Sheppard DN. Two mechanisms of genistein inhibition of cystic fibrosis transmembrane conductance regulator Cl− channels expressed in murine cell line. J Physiol 2000; 524: 317–330
   PubMed Web of Science ®Google Scholar
• Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990; 63: 827–834
   PubMed Web of Science ®Google Scholar
• Dalemans W, Barbry P, Champigny G, Jallat S, Dott K, Dreyer D, Crystal RG, Pavirani A, Lecocq J-P, Lazdunski M. Altered chloride ion channel kinetics associated with the ▵F508 cystic fibrosis mutation. Nature 1991; 354: 526–528
   PubMed Web of Science ®Google Scholar
• Ma T, Vetrivel L, Yang H, Pedemonte N, Zegarra-Moran O, Galietta LJV, Verkman AS. High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening. J Biol Chem 2002; 277: 37235–37241
   PubMed Web of Science ®Google Scholar
• Zhang Z-R, Zeltwanger S, McCarty NA. Direct comparison of NPPB and DPC as probes of CFTR expressed in Xenopus oocytes. J Membr Biol 2000; 175: 35–52
   Google Scholar
• Taddei A, Folli C, Zegarra-Moran O, Fanen P, Verkman AS, Galietta LJV. Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker. FEBS Lett 2004; 558: 52–56
   Google Scholar
• Yurko-Mauro KA, Reenstra WW. Prostaglandin F2α stimulates CFTR activity by PKA- and PKC-dependent phosphorylation. Am J Physiol 1998; 275: C653–660
   Google Scholar
• Vergani P, Lockless SW, Nairn AC, Gadsby DC. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 2005; 433: 876–880
   PubMed Web of Science ®Google Scholar
• Harrington MA, Gunderson KL, Kopito RR. Redox reagents and divalent cations alter the kinetics of cystic fibrosis transmembrane conductance regulator channel gating. J Biol Chem 1999; 274: 27536–27544
   Google Scholar
• Fischer H, Schwarzer C, Illek B. Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci USA 2004; 101: 3691–3696
   PubMed Web of Science ®Google Scholar
• Wang F, Zeltwanger S, Yang ICH, Nairn AC, Hwang T-C. Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating: Evidence for two binding sites with opposite effects. J Gen Physiol 1998; 111: 477–490
   Google Scholar
• Hallows KR, Raghuram V, Kemp BE, Witters LA, Foskett JK. Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase. J Clin Invest 2000; 105: 1711–1721
   PubMedGoogle Scholar
• Gadsby DC, Nairn AC. Control of cystic fibrosis transmembrane conductance regulator channel gating by phosphorylation and nucleotide hydrolysis. Physiol Rev 1999; 79: S77–107
   PubMedGoogle Scholar
• Cai Z, Sheppard DN. Phloxine B interacts with the cystic fibrosis transmembrane conductance regulator at multiple sites to modulate channel activity. J Biol Chem 2002; 277: 19546–19553
   PubMedGoogle Scholar
• Winter MC, Welsh MJ. Stimulation of CFTR activity by its phosphorylated R domain. Nature 1997; 389: 294–296
   PubMed Web of Science ®Google Scholar
• Jia Y, Mathews CJ, Hanrahan JW. Phosphorylation by protein kinase C is required for acute activation of cystic fibrosis transmembrane conductance regulator by protein kinase A. J Biol Chem 1997; 272: 4978–4984
   Google Scholar
• Moran O, Galietta LJV, Zegarra-Moran O. Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains. Cell Mol Life Sci 2005; 62: 446–460
   PubMed Web of Science ®Google Scholar
• Dawson RJP, Locher KP. Structure of a bacterial multidrug ABC transporter. Nature 2006; 443: 180–185
   PubMed Web of Science ®Google Scholar
• Serohijos AWR, Hegedus T, Aleksandrov AA, He L, Cui L, Dokholyan NV, Riordan JR. Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci USA 2008; 105: 3256–3261
   PubMed Web of Science ®Google Scholar
• Mornon J-P, Lehn P, Callebaut I. Atomic model of human cystic fibrosis transmembrane conductance regulator: Membrane-spanning domains and coupling interfaces. Cell Mol Life Sci 2008; 65: 2594–2612
   Google Scholar
• Hwang T-C, Koeppe RE II, Andersen OS. Genistein can modulate channel function by a phosphorylation-independent mechanism: Importance of hydrophobic mismatch and bilayer mechanics. Biochemistry 2003; 42: 13646–13658
   Google Scholar
• Artigas P, Al'aref SJ, Hobart EA, Díaz LF, Sakaguchi M, Straw S, Andersen OS. 2,3-butanedione monoxime affects cystic fibrosis transmembrane conductance regulator channel function through phosphorylation-dependent and phosphorylation-independent mechanisms: The role of bilayer material properties. Mol Pharmacol 2006; 70: 2015–2026
   Google Scholar
• Rich DP, Berger HA, Cheng SH, Travis SM, Saxena M, Smith AE, Welsh MJ. Regulation of the cystic fibrosis transmembrane conductance regulator Cl( channel by negative charge in the R domain. J Biol Chem 1993; 268: 20259–20267
   PubMed Web of Science ®Google Scholar
• Cai Z, Chen J-H, Hughes LK, Li H, Sheppard DN. The physiology and pharmacology of the CFTR Cl( channel. Chloride movements across cellular membranes, M Pusch. Elsevier Ltd, San Diego 2007; 109–143
   Google Scholar
• Vergani P, Lockless SW, Nairn AC, Gadsby DC. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 2005; 433: 876–880
   PubMed Web of Science ®Google Scholar
• Cai Z, Taddei A, Sheppard DN. Differential sensitivity of the cystic fibrosis (CF)-associated mutants G551D and G1349D to potentiators of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl( channel. J Biol Chem 2006; 281: 1970–1977
   PubMed Web of Science ®Google Scholar
• Loudon GM. Organic chemistry4th ed. Oxford University Press, New York 2002; 318
   Google Scholar
• Harrington MA, Gunderson KL, Kopito RR. Redox reagents and divalent cations alter the kinetics of cystic fibrosis transmembrane conductance regulator channel gating. J Biol Chem 1999; 274: 27536–27544
   Google Scholar
• Fischer H, Schwarzer C, Illek B. Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci USA 2004; 101: 3691–696
   PubMed Web of Science ®Google Scholar